According to Wall Street analysts, Cathy Wood just had her best month yet as her innovation stocks made big comebacks, and some of her darlings are still ahead by double digits. Wood’s flagship Arc Innovation ETF (ARKK) jumped 27.8% in January alone, its strongest month ever since its inception in 2014. The big rally came after a brutal year in which ARKK lost 67% due to rising interest rates. CNBC checked out the stocks in the fund that have more room to run this year. We looked at companies with at least five analysts, and all of these names are up more than 10% over the next 12 months, according to FactSet. Wall Street analysts are among the most bullish on Ginkgo Bioworks, seeing the stock rise more than 140% over the next 12 months. The stock is up about 17% this year after an 80% selloff in 2022. The widely-followed investor previously stated that the investing trend in DNA development is “one of the most misunderstood and under-appreciated.” Ark Invest has a specific exchange-traded fund dedicated to this space: the ARK Genomic Revolution ETF (ARKG) Intellia Therapeutics is also a genomics play in ARKG’s portfolio. Analysts estimate the stock could soar 140% over the next 12 months. Other biotech names in the sector that analysts like are Verve Therapeutics, CRISPR Therapeutics, Beam Therapeutics, and Twist Bioscience. The innovation investor previously said the gene-editing space could be at least a $1 trillion opportunity. She said she is particularly excited about companies that use CRISPR-Cas9, a technology that enables geneticists and medical researchers to edit parts of the genome, including CRISPR Therapeutics and Intellia Therapeutics. . Aside from health care, the sports betting company is well-liked by DraftKings analysts, who project an average of 22% upside for the stock over the next 12 months. With a weighting of 3.4% in the 29-stock portfolio, DraftKings is the 15th largest holding in ARKK. Software company Twilio also made the list as analysts see 18.5% upside for the stock. Twilio is the 10th largest holding in Wood’s ARKK portfolio with a weighting of 3.8%. Twilio shares are up more than 25% this year alone after plunging 81% last year. Wood recently reiterated his high confidence in his disruptive innovation strategy, betting on the market value of these companies compounding 40% annually to reach $200 trillion by 2030.